HIV感染者持续性IL-6升高相关因素分析
基于START试验中2102例HIV感染者的纵向IL-6监测数据,41%存在持续性高炎症(IL-6>1.8 pg/mL连续≥2次),27%出现IL-6短暂升高。BMI≥40、黑人女性、高WBC、高HIV-1 RNA、胆固醇比值>5、年龄、吸烟和糖尿病与持续性高炎症相关,而短暂升高仅与高WBC相关。
要点
- 持续性高炎症定义为IL-6>1.8 pg/mL连续≥2次,需与单次短暂升高区分
- BMI≥40者持续性高炎症风险显著升高(OR 5.49),黑人女性风险亦升高(OR 2.58)
- 持续性高炎症与代谢、免疫激活及病毒学因素相关,短暂升高仅与WBC相关
核心结论
- 持续性高炎症与人口学特征、合并症及HIV-1 RNA强相关,而IL-6短暂升高与免疫激活标志物相关。
- 纵向IL-6监测有助于区分持续性高炎症与短暂升高,为建立高危表型提供依据。
研究设计与样本
- 基于START试验的子集分析,纳入2102例HIV感染者,中位随访5年(IQR 4-6)的IL-6测量。
- IL-6在随机化时、第8月、第12月及每年至84月检测,采用广义估计方程分析相关因素。
主要发现
- 861例(41%)存在持续性高炎症,575例(27%)出现IL-6短暂升高。
- BMI≥40 vs 18.5-<25者持续性高炎症OR为5.49(95%CI 4.18-7.20)。
- 黑人女性 vs 白人男性持续性高炎症OR为2.58(95%CI 2.17-3.06)。
- 持续性高炎症其他预测因素包括高WBC、高HIV-1 RNA、总胆固醇/HDL比值>5、年龄、吸烟和糖尿病。
- 仅高WBC同时与IL-6短暂升高相关。
关键数值与推荐
- 高炎症定义为IL-6>1.8 pg/mL;连续≥2次升高定义为持续性高炎症;单次升高前后均为非升高定义为IL-6短暂升高。
临床怎么用
- 对HIV感染者应纵向监测IL-6以区分持续性高炎症与短暂升高,识别高危表型。
- 对BMI≥40、黑人女性、高WBC、高HIV-1 RNA、胆固醇比值>5、吸烟及糖尿病者应警惕持续性高炎症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Individuals with HIV remain at higher risk of non-communicable diseases associated with interleukin-6-specific (IL-6) inflammation compared to the background population. Despite antiretroviral therapy, some individuals exhibit persistent hyperinflammation. We characterise these understudied longitudinal profiles and distinguish the predictors of chronic versus acute inflammation. METHODS: A subset from the Strategic Timing of Antiretroviral Treatment (START) trial with up to seven years of biomarker follow-up was included. Inflammatory states were defined based on plasma IL-6 levels, measured at randomisation, months eight, 12, and annually until 84. Hyperinflammation was defined as IL-6>1.8 pg/mL; ≥2 consecutive elevated measurements defined persistent hyperinflammation and a single elevated bracketed by non-elevated measurements defined IL-6 blips. Variables associated with these outcomes were analysed by generalized estimating equations. RESULTS: Among 2,102 individuals with a median of 5 (IQR: 4-6) measurements, 861 (41%) had persistent hyperinflammation whereas 575 (27%) had blips. Participants with BMI≥40 versus 18.5 to <25 (OR: 5.49, 95%CI: 4.18-7.20) and females with black ethnicity versus white males (2.58, 2.17-3.06) had increased risk of persistent hyperinflammation but not blips. Other persistent hyperinflammation predictors included higher white blood cell (WBC) counts, HIV-1 RNA, total cholesterol to high-density lipoprotein ratio >5, older age, smoking and diabetes. Of these only higher WBCs were also associated with blips. CONCLUSIONS: Persistent hyperinflammation is strongly associated with demographic characteristics, comorbidities, and HIV-1 RNA, whereas blips were associated with markers of immune activation. Longitudinal IL-6 measurements are needed to distinguish persistent hyperinflammation from blips, which can lead to establishing a "high-risk phenotype" to target for clinical intervention.
引用
- Kjærgaard VS, Ledergerber B, Bannister W, et al. Factors Associated with Persistently Increased IL-6 Levels in People with HIV. J Infect Dis. 2026. PMID: 42686567. doi:10.1093/infdis/jiag451
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。